News . Data . Research
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) Q4 2021 earnings call, dated Nov. 22, 2021. Corporate Participants: Vince Anzalone -- Vice President of Investor Relations Christopher
Cara Therapeutics, Inc. (NASDAQ: CARA) Q3 2021 earnings call dated Nov. 08, 2021 Corporate Participants: Will Gramig -- Senior Analyst Derek Chalmers -- Chief Executive Officer,
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business
Evelo Biosciences Inc (NASDAQ: EVLO) Q3 2021 earnings call dated Oct. 28, 2021 Corporate Participants: Kendra Sweeney -- Head of Investor Relations
Credit:DavidBGray on iStock What’s the significance of the name change and why now? Mike: The why now is because we have really
Avid Bioservices Inc (NASDAQ: CDMO) Q1 2021 earnings call dated Sep. 08, 2021. Corporate Participants: Tim Brons -- Avid's Investor Relations Group Nicholas
Just eight months into the year, IPO activity has already reached all-time highs, with tech firms and biotechnology startups leading the rally.
Shares of Moderna Inc. (NASDAQ: MRNA) were up 6% on Monday. The stock has gained 291% since the beginning of the year
The medical device market has been in the spotlight ever since coronavirus tightened its grip across the world last year as the
As healthcare startups continue to flock to the stock market, extending the hectic activity seen in the first half, the IPO market
Cara Therapeutics, Inc. (NASDAQ: CARA) Q2 2021 earnings call dated Aug. 09, 2021 Corporate Participants: Cole Herlitz-Ferguson -- Investor Relations Derek Chalmers -- Chief Executive Officer,
Extending the IPO frenzy that sweeped the market in the early part of the year, emerging biotechnology companies continue to flock to
Moderna, Inc. (NASDAQ: MRNA) Q2 2021 earnings call dated Aug. 05, 2021 Corporate Participants: Lavina Talukdar -- Senior Vice President & Head of Investor
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q2 2021 earnings call dated Aug. 03, 2021 Corporate Participants: Andrea N. Flynn -- Vice President and Head of
The favorable regulatory environment and convenient options like direct listing continue to lure emerging businesses to the stock market. The latest statistics
In the first half of 2021, a record number of private companies entered stock markets in the US, marking a multifold increase
ImmunoGen Inc. (NASDAQ: IMGN) Q2 2021 earnings call dated Jul. 30, 2021 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor
Gilead Sciences Inc (NASDAQ: GILD) Q2 2021 earnings call dated Jul. 29, 2021. Corporate Participants: Jacquie Ross -- Investor Relations Daniel O'Day --
Of late healthcare firms have been flocking to Wall Street, betting on the booming stock market to take their business expansion to
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday said its second-quarter earnings and revenues decreased from last year. The results, however, came in
Wall Street is probably going through the busiest phase since the recession, in terms of the number of businesses seeking to go